Review




Structured Review

Sinovac BioTech picovacc coronavac
Picovacc Coronavac, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/coronavac++picovacc+/pm39559970-35-10-12
Average 90 stars, based on 1 article reviews
picovacc coronavac - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Infection:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Plasmid Preparation:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Formulation:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Vaccines:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Recombinant:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Expressing:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Bioprocessing:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Virus:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.

Adjuvant:

Article Title: Immunization against severe acute respiratory syndrome Coronavirus 2: an overview
Article Snippet: 90,91 CoronaVac (previously named PiCoVacc) is a formulated alum-enhanced vaccine inactivated with formalin, developed by the China-based biotechnology company Sinovac Biotech., 90 COVID-19 Vaccine AstraZeneca (AZD1222); also called Covishield: AstraZeneca and the Oxford Vaccine Group at the University of Oxford have developed “COVID-19 Vaccine AstraZeneca” (formerly AZD1222 and ChAdOx1), which is a vaccine against the adenovirus chimpanzee.



Similar Products

90
Sinovac BioTech picovacc coronavac
Picovacc Coronavac, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/coronavac++picovacc+/pm39559970-35-10-12
Average 90 stars, based on 1 article reviews
picovacc coronavac - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sinovac BioTech coronavac picovacc
Vaccine effectiveness against SARS-CoV-2 Variants
Coronavac Picovacc, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/coronavac++picovacc+/pmc09569411-7-5-2
Average 90 stars, based on 1 article reviews
coronavac picovacc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sinovac BioTech coronavac (picovacc)
Vaccine effectiveness against SARS-CoV-2 Variants
Coronavac (Picovacc), supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/coronavac++picovacc+/pmc09569411-110-0-16
Average 90 stars, based on 1 article reviews
coronavac (picovacc) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sinovac BioTech coronavac/ pi picovacc
Vaccine effectiveness against SARS-CoV-2 Variants
Coronavac/ Pi Picovacc, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/coronavac++picovacc+/pmc08991668-5-4-7
Average 90 stars, based on 1 article reviews
coronavac/ pi picovacc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sinovac BioTech inactivated whole-virus vaccine coronavac/picovacc
Vaccine effectiveness against SARS-CoV-2 Variants
Inactivated Whole Virus Vaccine Coronavac/Picovacc, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/inactivated+virus/pmc08991668-73-2-7
Average 90 stars, based on 1 article reviews
inactivated whole-virus vaccine coronavac/picovacc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sinovac BioTech covid-19 vaccine (vero cell) inactivated (coronavac (formerly picovacc
Vaccine effectiveness against SARS-CoV-2 Variants
Covid 19 Vaccine (Vero Cell) Inactivated (Coronavac (Formerly Picovacc, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/covid+19+vaccine/pmc08843115-193-5-10
Average 90 stars, based on 1 article reviews
covid-19 vaccine (vero cell) inactivated (coronavac (formerly picovacc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sinopharm ltd coronavac/picovacc
Vaccine effectiveness against SARS-CoV-2 Variants
Coronavac/Picovacc, supplied by Sinopharm ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/coronavac+picovacc/pmc08226851-39-2-9
Average 90 stars, based on 1 article reviews
coronavac/picovacc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Sinovac BioTech coronavac(picovacc
SARS-CoV-2 vaccine candidates from various platforms in clinical trials
Coronavac(picovacc, supplied by Sinovac BioTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/coronavac+picovacc/coronavac++picovacc+/pmc07996120-17-3-7
Average 90 stars, based on 1 article reviews
coronavac(picovacc - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Vaccine effectiveness against SARS-CoV-2 Variants

Journal: Journal of Biomedical Science

Article Title: COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

doi: 10.1186/s12929-022-00853-8

Figure Lengend Snippet: Vaccine effectiveness against SARS-CoV-2 Variants

Article Snippet: 8 , Sinovac Biotech , CoronaVac (PiCoVacc) , Inactivated , 56 , 50.7% (Brazil) 65.3% (Indonesia) 83.5% (Turkey) , 100% (Brazil) , [ – ] .

Techniques: Infection

Vaccine list and efficacy (as of August 2022)

Journal: Journal of Biomedical Science

Article Title: COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

doi: 10.1186/s12929-022-00853-8

Figure Lengend Snippet: Vaccine list and efficacy (as of August 2022)

Article Snippet: 8 , Sinovac Biotech , CoronaVac (PiCoVacc) , Inactivated , 56 , 50.7% (Brazil) 65.3% (Indonesia) 83.5% (Turkey) , 100% (Brazil) , [ – ] .

Techniques: Infection, Plasmid Preparation, Formulation

Vaccine effectiveness against SARS-CoV-2 Variants

Journal: Journal of Biomedical Science

Article Title: COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

doi: 10.1186/s12929-022-00853-8

Figure Lengend Snippet: Vaccine effectiveness against SARS-CoV-2 Variants

Article Snippet: CoronaVac (PiCoVacc) is a beta-propiolactone inactivated, Vero cell line propagated, alum-adjuvanted whole inactivated vaccine developed by Sinovac Biotech.

Techniques: Infection

Vaccine list and efficacy (as of August 2022)

Journal: Journal of Biomedical Science

Article Title: COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection

doi: 10.1186/s12929-022-00853-8

Figure Lengend Snippet: Vaccine list and efficacy (as of August 2022)

Article Snippet: CoronaVac (PiCoVacc) is a beta-propiolactone inactivated, Vero cell line propagated, alum-adjuvanted whole inactivated vaccine developed by Sinovac Biotech.

Techniques: Infection, Plasmid Preparation, Formulation

SARS-CoV-2 vaccine candidates from various platforms in clinical trials

Journal: Probiotics and Antimicrobial Proteins

Article Title: The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development

doi: 10.1007/s12602-021-09773-9

Figure Lengend Snippet: SARS-CoV-2 vaccine candidates from various platforms in clinical trials

Article Snippet: Inactivated Virus , CoronaVac(PiCoVacc) , Spike , Sinovac Biotech/ , NCT04352608.

Techniques: Plasmid Preparation